Lifepoint Health and Eon Reveal Key Insights on Breast Cancer Detection Through Incidental Findings
In a significant advancement in breast cancer detection, Lifepoint Health and Eon have released new data that highlights the critical role of identifying incidental findings. This large-scale study outlines how patients diagnosed through incidental findings during imaging procedures have a 6.2 times higher likelihood of being diagnosed with breast cancer compared to those undergoing routine screening mammograms.
The findings indicate that more than 63% of patients who were ultimately diagnosed with cancer had already been classified as high-risk during their initial examination. Surprisingly, over half of these diagnoses were made among patients who typically do not qualify for routine screenings, including individuals who are too young, too old, or male. This revelation underscores the importance of expanding follow-up protocols beyond the conventional framework of screening.
Dr. Aki Al-Zubaidi, the CEO of Eon, stated, "For decades, breast cancer detection programs have revolved primarily around screening mammography. While this method is undeniably essential, it is not sufficient on its own. The data we collected demonstrates that some of the highest-risk patients are identified through imaging conducted for unrelated clinical reasons."
The analysis utilized the Eon Breast platform, which is specifically designed to track and manage patients needing follow-up for both routine screenings and incidental breast findings discovered during other imaging procedures. By integrating these incidental findings into a cohesive screening workflow, health systems can enhance care coordination and management for patients requiring immediate attention.
Lifepoint Health's initiative was initiated after a comprehensive retrospective analysis of 5.6 million reports revealed a pressing need for follow-up on 1,685 patients with incidental breast abnormalities. Notably, more than 40% of these individuals did not conform to the American Cancer Society's clinical guidelines, which recommended routine screenings for women aged 45 to 75. As a response, Lifepoint launched an effort to closely monitor and manage incidentally detected breast lesions, augmenting their existing screening programs.
The integration of Eon Breast into Lifepoint's diagnostic protocols has resulted in early diagnosis of patients at risk and enhanced operational efficiency. Bart Daugherty, Vice President of Clinical Technology and Systems at Lifepoint, remarked, "Initially, we had 53 different breast programs, each with distinct workflows. Now, we can uniformly manage both screening and incidental findings within one system across all facilities. Eon Breast has allowed us to handle more patients and has freed up nearly four hours weekly per site, amounting to a total of 208 hours annually that can be redirected toward patient care."
Lifepoint Health is dedicated to creating initiatives that span various health issues, including lung, pancreas, kidney, liver, thyroid, and aortic aneurysms, thanks to the capabilities of Eon's AI platform. The company's incidental findings management program, recognized as one of the most comprehensive in the United States, has identified over 100,000 high-risk abnormalities, resulting in a remarkable 36% increase in early-stage cancer diagnoses. Dr. Chris Frost, Lifepoint's Senior Vice President, affirmed, "The Healthy Person Program was founded on the belief that systematic identification and management of at-risk patients could lead to better outcomes. With Eon's integrated solution, we successfully merged incidental findings into our diagnostic efforts and ensured patients receive timely follow-ups without overwhelming our existing staff."
Eon Breast is now available for all health systems wishing to enhance breast cancer detection. For further information, visit www.eonhealth.com/breast.
Lifepoint Health is a prominent healthcare provider focused on serving patients, communities, and partner organizations throughout the healthcare continuum. The organization operates a wide-ranging healthcare delivery network, including nearly 55,000 dedicated employees, 60 community hospital campuses, over 70 rehabilitation and behavioral health hospitals, and more than 300 additional care sites, all underpinned by their mission to make communities healthier. For more information, visit www.LifepointHealth.net.
Eon is a healthcare technology innovator dedicated to assisting health systems in detecting cancer risks earlier and ensuring timely follow-ups and ongoing patient care. Their platform facilitates the identification of incidental findings in radiology reports and provides tracking for patients through completed care, optimized by a team of navigators to support care coordination and outreach. With more than 500 million radiology reports analyzed, Eon currently serves over 75 health systems across more than 1,200 facilities. To learn more, visit www.eonhealth.com.
The findings indicate that more than 63% of patients who were ultimately diagnosed with cancer had already been classified as high-risk during their initial examination. Surprisingly, over half of these diagnoses were made among patients who typically do not qualify for routine screenings, including individuals who are too young, too old, or male. This revelation underscores the importance of expanding follow-up protocols beyond the conventional framework of screening.
Dr. Aki Al-Zubaidi, the CEO of Eon, stated, "For decades, breast cancer detection programs have revolved primarily around screening mammography. While this method is undeniably essential, it is not sufficient on its own. The data we collected demonstrates that some of the highest-risk patients are identified through imaging conducted for unrelated clinical reasons."
The analysis utilized the Eon Breast platform, which is specifically designed to track and manage patients needing follow-up for both routine screenings and incidental breast findings discovered during other imaging procedures. By integrating these incidental findings into a cohesive screening workflow, health systems can enhance care coordination and management for patients requiring immediate attention.
Lifepoint Health's initiative was initiated after a comprehensive retrospective analysis of 5.6 million reports revealed a pressing need for follow-up on 1,685 patients with incidental breast abnormalities. Notably, more than 40% of these individuals did not conform to the American Cancer Society's clinical guidelines, which recommended routine screenings for women aged 45 to 75. As a response, Lifepoint launched an effort to closely monitor and manage incidentally detected breast lesions, augmenting their existing screening programs.
The integration of Eon Breast into Lifepoint's diagnostic protocols has resulted in early diagnosis of patients at risk and enhanced operational efficiency. Bart Daugherty, Vice President of Clinical Technology and Systems at Lifepoint, remarked, "Initially, we had 53 different breast programs, each with distinct workflows. Now, we can uniformly manage both screening and incidental findings within one system across all facilities. Eon Breast has allowed us to handle more patients and has freed up nearly four hours weekly per site, amounting to a total of 208 hours annually that can be redirected toward patient care."
Lifepoint Health is dedicated to creating initiatives that span various health issues, including lung, pancreas, kidney, liver, thyroid, and aortic aneurysms, thanks to the capabilities of Eon's AI platform. The company's incidental findings management program, recognized as one of the most comprehensive in the United States, has identified over 100,000 high-risk abnormalities, resulting in a remarkable 36% increase in early-stage cancer diagnoses. Dr. Chris Frost, Lifepoint's Senior Vice President, affirmed, "The Healthy Person Program was founded on the belief that systematic identification and management of at-risk patients could lead to better outcomes. With Eon's integrated solution, we successfully merged incidental findings into our diagnostic efforts and ensured patients receive timely follow-ups without overwhelming our existing staff."
Eon Breast is now available for all health systems wishing to enhance breast cancer detection. For further information, visit www.eonhealth.com/breast.
About Lifepoint Health
Lifepoint Health is a prominent healthcare provider focused on serving patients, communities, and partner organizations throughout the healthcare continuum. The organization operates a wide-ranging healthcare delivery network, including nearly 55,000 dedicated employees, 60 community hospital campuses, over 70 rehabilitation and behavioral health hospitals, and more than 300 additional care sites, all underpinned by their mission to make communities healthier. For more information, visit www.LifepointHealth.net.
About Eon
Eon is a healthcare technology innovator dedicated to assisting health systems in detecting cancer risks earlier and ensuring timely follow-ups and ongoing patient care. Their platform facilitates the identification of incidental findings in radiology reports and provides tracking for patients through completed care, optimized by a team of navigators to support care coordination and outreach. With more than 500 million radiology reports analyzed, Eon currently serves over 75 health systems across more than 1,200 facilities. To learn more, visit www.eonhealth.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.